Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M231,776Revenue $M54,395Net Margin (%)23.2Z-Score3.7
Enterprise Value $M248,138EPS $1.9Operating Margin %34.3F-Score5
P/E(ttm))23.4Cash Flow Per Share $0Pre-tax Margin (%)31.0Higher ROA y-yN
Price/Book10.010-y EBITDA Growth Rate %2.1Quick Ratio1.0Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %3.5Current Ratio1.4Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %-50.2ROA % (ttm)16.2Higher Current Ratio y-yN
Dividend Yield %3.2Insider Buy (3m)0ROE % (ttm)51.8Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M6,795ROI % (ttm)33.6Gross Margin Increase y-yN

Gurus Latest Trades with RHHBY

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RHHBYKen Fisher 2014-12-31 Add0.07%$34.16 - $37.92
($36.33)
$ 34.38-5%Add 49.26%2,823,025
RHHBYKen Fisher 2014-06-30 Reduce-0.07%$35.42 - $38.07
($36.82)
$ 34.38-7%Reduce -49.71%1,813,443
RHHBYKen Fisher 2014-03-31 Add0.07%$18.14 - $38.17
($29.75)
$ 34.3816%Add 99%1,803,070
RHHBYTweedy Browne 2013-06-30 Sold Out $28.92 - $32.98
($30.92)
$ 34.3811%Sold Out0
RHHBYKen Fisher 2013-03-31 Add0.12%$25.25 - $29.3
($27.74)
$ 34.3824%Add 634.57%897,861
RHHBYTweedy Browne 2012-09-30 Reduce-0.03%$20.95 - $24.07
($22.41)
$ 34.3853%Reduce -24.31%62,164
RHHBYVanguard Health Care Fund 2012-06-30 Add2.96%$19.47 - $23.14
($21.16)
$ 34.3862%Add 543.36%4,273,977
RHHBYKen Fisher 2012-06-30 Reduce-0.01%$19.47 - $23.14
($21.16)
$ 34.3862%Reduce -24.26%154,713
RHHBYKen Fisher 2012-03-31 Reduce-1.27%$21.55 - $22.17
($20.04)
$ 34.3872%Reduce -98.02%204,276
RHHBYTweedy Browne 2012-03-31 Reduce-0.04%$21.55 - $22.17
($20.04)
$ 34.3872%Reduce -22.19%82,130
RHHBYKen Fisher 2009-03-31 Add1.01%$13.37 - $18.53
($15.95)
$ 34.38116%Add 96.11%12,225,393
RHHBYVanguard Health Care Fund 2009-03-31 Reduce-0.2%$13.37 - $18.53
($15.95)
$ 34.38116%Reduce -52.1%429,320
RHHBYVanguard Health Care Fund 2008-12-31 Add2.01%$31.33 - $38.5
($35.55)
$ 34.38-3%Add 95.76%5,113,297
RHHBYPRIMECAP Management 2008-12-31 Sold Out -1.2%$31.33 - $38.5
($35.55)
$ 34.38-3%Sold Out0
RHHBYKen Fisher 2008-12-31 Reduce-1.15%$8.06 - $19.92
($17.52)
$ 34.3896%Reduce -56.79%6,233,841
RHHBYPRIMECAP Management 2008-09-30 Buy 1.2%$20.05 - $22.89
($21.5)
$ 34.3860%New holding, 4306500 sh.4,306,500
RHHBYKen Fisher 2008-06-30 Add1.14%$19.95 - $23.69
($21.4)
$ 34.3861%Add 223.59%7,046,449
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RHHBY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
RHHBY Ken Fisher 2014-12-312,823,0250.040.2+49.26%
RHHBY Ken Fisher 2014-09-301,891,4060.030.15+4.3%
Premium Most recent portfolio changes are included for Premium Members only!


RHHBY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RHHBY :

    Quarterly/Annual Reports about RHHBY:

      News about RHHBY:

      Articles On GuruFocus.com
      Pharmaceuticals Sector To See High Voltage Action in 2015 Jan 23 2015 
      Roche In Expansion Mode Jan 19 2015 
      Why Organovo is A Safe Buy? Dec 18 2014 
      Is Organovo A Safe Buy? Dec 08 2014 
      The Top 5 European Stocks Held During Q3 Nov 25 2014 
      Tweedy Browne Global Reports its Top Five Picks of Q3 Oct 21 2014 
      Widely Held Guru Stocks Trading In Europe Sep 22 2014 
      Dodge & Cox Second Quarter 2014 Commentary Jul 23 2014 
      Tweedy Browne Global Reports Their Second Quarter Portfolio Jul 18 2014 
      Signature Select Canadian Fund's Top Holdings Jul 02 2014 

      More From Our Partners
      Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog Jan 22 2015 - ZACKS

      More From Other Websites
      Roche Misses on Earnings in 2014, Beats on Revenues - Analyst Blog Jan 29 2015
      Roche and Qualcomm Collaborate to Innovate Remote Patient Monitoring Jan 29 2015
      2:25 am Roche Hldg receives FDA clearance for next generation cobas MRSA/SA Test Jan 27 2015
      AstraZeneca's Regulatory Filing for Lesinurad Accepted - Analyst Blog Jan 26 2015
      Roche receives FDA clearance for next generation cobas MRSA/SA Test Jan 26 2015
      Putting the spotlight on Illumina Jan 23 2015
      Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog Jan 22 2015
      Investment Bets On Antibiotics To Help Invigorate Investor Portfolios Jan 21 2015
      Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer... Jan 21 2015
      Evotec Signs New Deal for Addictive Disorder Therapies - Analyst Blog Jan 20 2015
      Roche to Acquire French Biotechnology Company Trophos - Analyst Blog Jan 19 2015
      Amgen (AMGN) Reveals Mixed Results from Vectibix Studies - Analyst Blog Jan 16 2015
      Watchmakers Caught In The #Francogeddon Storm Jan 16 2015
      A First in North America: CDL Laboratories acquire the latest technology in laboratory analysis from... Jan 15 2015
      Own Swiss ADRs? It's better to be lucky than good Jan 15 2015
      Swiss ADRs Rise as Franc Surges Jan 15 2015
      Why Transparency And Data Sharing In Clinical Trials Matters Jan 15 2015
      European Stocks Trade Mixed After Switzerland Scraps Euro Exchange Cap Jan 15 2015
      Roche to Acquire Up to 56% Interest in Foundation Medicine - Analyst Blog Jan 14 2015
      AstraZeneca Inks Immuno-Oncology Agreement with Omnis - Analyst Blog Jan 14 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      Steve.dunfield@google
      ReplySteve.dunfield@google - 10 months ago
      Adjust for split?
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK